1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Medicines for Smoking Cessation: Global Markets

Medicines for Smoking Cessation: Global Markets

  • September 2013
  • -
  • BCC Research
  • -
  • 119 pages

STUDY GOALS AND OBJECTIVES

This BCC Research report analyzes the global trends in smoking cessation. Public health departments and national regulatory agencies are working to create awareness on the health hazards of smoking. Their efforts are to educate, counsel and prevent people from smoking. Smoking cessation medications are used to help patients cope with the withdrawal symptoms of smoking and nicotine dependence and assist them in quitting smoking completely.
The objective of this study is to understand current market trends, future prospects and opportunities in nicotine dependence treatments. The report will assess the role of smoking cessation medicines in improving the quit rate. It will bring out the key result areas of smoking cessation medicines and will address the areas that need improvement.

REASONS FOR DOING THE STUDY

Reducing the prevalence of smoking is a national agenda of many nations, including emerging markets. This development provides an opportunity to manufacturers and marketers of smoking cessation medicines to expand organically. The study will help in understanding the length and breadth of the market as well as initiate strategies.

SCOPE OF REPORT

The report covers developed and emerging markets in order to help readers understand:
• The current state of the smoking cessation market and the key markets for its future development.
• New technologies that will influence the development of smoking cessation products.
• Market drivers and threats for the smoking cessation medicine industry.
• Major regional trends in the global smoking cessation market.
• Competitive analysis of the market.
• Branded versus generic, and over-the-counter versus prescription for nicotine replacements, non-nicotine and antidepressants.

INTENDED AUDIENCE

• Executives of pharmaceutical companies who are currently marketing smoking cessation aids.
• Executives of companies that provide third-party manufacturing and development facilities for smoking cessation medications.
• Manufacturers of gum base, resins, alkaloids and other raw materials for the manufacturing of nicotine replacement therapies.
• Developers of novel nicotine delivery systems.
• Tobacco companies that intend to enter the tobacco transformation market.
• Entrepreneurs, management consultants, and merger and acquisition (M&A) consultants.
• Financial institutions, venture capitalists and angel investors.
• Manufacturers and exporters of alternate smoking cessation aids.
• Government agencies, public health departments and organizations working in tobacco prevention and control.

INFORMATION SOURCES

The information and analysis presented in this BCC Research report are based on firsthand information from primary executives, product managers and clinical specialists; background information obtained from various government, business, medical journal and trade magazines; and statistical data from organizations such as the World Health Organization (WHO), the Organization for Economic Co-operation and Development (OECD), Centers for Disease Control (CDC), The Tobacco Atlas and others working in public health and tobacco control.
Key information from published literature was used to conduct interviews with industry participants to validate and obtain expert opinions on current and future trends. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as to formulate market projections. All market data pertain to the manufacturer’s level. Data are expressed in 2012 U.S. dollars. The base year was 2012. Historical data are provided for 2011 and forecast data are provided for 2013 and 2018. Historical, base year and forecast data are provided for each market segment and sub-segment. Market shares are provided for each market segment for the base year of 2012.

ANALYST CREDENTIALS

Anand Gijare has been authoring business reports as his main focus for the last five years. His domain expertise lays in the pharmaceutical, IT and telecom fields. He has a diploma in Financial Management, a PGDM in marketing and a Bachelor of Science degree in Chemistry.

BCC ONLINE SERVICES

BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
• Examine BCC’s complete catalog of Market Research Reports and place direct orders.
• Subscribe to any of BCC’s many industry newsletters.
• Read announcements of recently published reports and newly launched newsletters.
• Register for BCC’s well-known conferences.
• Request additional information on any BCC product.
• Take advantage of special offers.

REPORT HIGHLIGHTS

This report provides:
• An overview of the global market for medicines used to quit smoking, which help in coping with nicotine withdrawal symptoms developed after a long-term addiction to tobacco.
• Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
• Discussion of the history and current state of smoking cessation methods, worldwide trends in smoking, and mechanisms of actions, such as nicotine replacement therapy, nicotine receptor partial agonist, and antidepressants.
• A list of pipeline products and an in-depth focus on promising pipeline candidates, as well current patents and new applications.
• Comprehensive company profiles of major players in the industry.

Table Of Contents

Medicines for Smoking Cessation: Global Markets
TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 2

STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
SCOPE OF REPORT 2
INTENDED AUDIENCE 2
INFORMATION SOURCES 3
ANALYST CREDENTIALS 3
RELATED REPORTS 3
BCC ONLINE SERVICES 4
DISCLAIMER 4

CHAPTER 2 SUMMARY 6

SUMMARY TABLE SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY
REGION, THROUGH 2018 ($ MILLIONS) 8
SUMMARY FIGURE SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY
REGION, 2011-2018 ($ MILLIONS) 8

CHAPTER 3 OVERVIEW 12

SMOKING AND HEALTH HAZARDS 12
CURRENT TRENDS IN THE TOBACCO INDUSTRY 13
HEALTH HAZARDS OF SMOKING 14
METHODS OF SMOKING CESSATION 16
SMOKING CESSATION WITHOUT ASSISTANCE 16
SMOKING CESSATION WITH EXPERT INTERVENTIONS 18
SMOKING CESSATION WITH MEDICATION 18
HEALTH BENEFITS OF SMOKING CESSATION 18
TABLE 1 BENEFITS OF SMOKING CESSATION 19
TRENDS IN SMOKING CESSATION 20
ROLE OF NICOTINE 21
FIGURE 1 NICOTINE MOLECULE: 3-[(2S)-1-METHYLPYRROLIDINE-2-YL]PYRIDINE 21
UNDERSTANDING NICOTINE ADDICTION 22
TABLE 2 GENERAL CRITERIA FOR DRUG DEPENDENCE 23
UNDERSTANDING NICOTINE ABSORPTION MECHANISM 24
UNDERSTANDING WITHDRAWAL SYMPTOMS OF NICOTINE 25

CHAPTER 4 SMOKING CESSATION MEDICINES 28

TABLE 3 CLASSIFICATION OF SMOKING CESSATION MEDICINES BASED ON MODE
OF ACTION 29
NICOTINE REPLACEMENT THERAPY 29
TABLE 4 CLASSIFICATION OF NICOTINE REPLACEMENT THERAPY BASED ON DRUG
DELIVERY SYSTEM 29
NICOTINE REPLACEMENT THERAPY: ORAL MUCOSA DELIVERY SYSTEM 30
Nicotine Gum 30
TABLE 5 NICOTINE GUM DOSAGES AND SCHEDULES 30
Key Brands 31
TABLE 6 KEY BRANDS AND MARKETERS OF NICOTINE GUMS 32
Nicotine Lozenges 32
TABLE 7 NICOTINE LOZENGE DOSAGE AND SCHEDULE 32
TABLE 8 KEY BRANDS AND MARKETERS OF NICOTINE LOZENGES 33
Nicotine Tablets 33
TABLE 9 KEY BRANDS AND MARKETERS OF NICOTINE TABLETS 34
Nicotine Inhalers 34
TABLE 10 KEY BRANDS AND MARKETERS OF NICOTINE INHALERS 34
Nicotine Mouth Sprays 35
TABLE 11 KEY BRANDS AND MARKETERS OF NICOTINE MOUTH SPRAYS 35
NICOTINE REPLACEMENT THERAPY: TRANSDERMAL DELIVERY SYSTEM 35
Nicotine Patches 35
TABLE 12 NICOTINE PATCH DOSAGE AND SCHEDULE 36
TABLE 13 KEY BRANDS AND MARKETERS OF NICOTINE PATCHES 37
NICOTINE REPLACEMENT THERAPY: NASAL DELIVERY SYSTEM 37
Nicotine Nasal Sprays 37
TABLE 14 KEY BRANDS AND MARKETERS OF NICOTINE NASAL SPRAYS 37
NON-NICOTINE THERAPIES 38
CHANTIX/CHAMPIX (VARENICLINE TARTRATE) 38
Mechanism of Action 38
Marketing 38
TABLE 15 CHANTIX/CHAMPIX SALES REVENUE, 2007-2012 ($ MILLIONS) 39
Zyban (bupropion HCl) 39
RandD IN SMOKING CESSATION MEDICINES 40
DEVELOPMENTS IN THE PIPELINE (NICOTINE REPLACEMENT THERAPY) 40
NICOTINE VACCINES 40
TABLE 16 NICOTINE VACCINES IN DEVELOPMENT PHASE AS OF JANUARY 2013 41
NICOTINE ORALLY DISSOLVABLE FILMS 41
VERY LOW NICOTINE CIGARETTES 42
CYTISINE (TABEX) 42
DEVELOPMENTS IN THE PIPELINE (NON-NICOTINE THERAPY) 43
TABLE 17 DEVELOPMENTS IN THE PIPELINE (NON-NICOTINE) 43
GSK598809 SELECTIVE D3 RECEPTOR ANTAGONIST 44
D-CYCLOSERINE 44
TABLE 18 CLINICAL TRIALS OF D-CYCLOSERINE 44
EVT 302 44
SELEGILINE 45
NALMEFENE 45

CHAPTER 5 THE GLOBAL SMOKING CESSATION MEDICINE MARKET 47

SMOKING CESSATION MARKET REVENUE, 2012 47
SMOKING CESSATION MEDICINE MARKET FORECAST, 2013-2018 47
TABLE 19 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST, THROUGH
2018 ($ MILLIONS) 48
FIGURE 2 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST, 2011-2018
($ MILLIONS) 48
GLOBAL MARKET FORECAST BY CLASSIFICATION OF SMOKING CESSATION
MEDICINES, 2013-2018 49
TABLE 20 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST BY
CLASSIFICATION, THROUGH 2018 ($ MILLIONS) 49
FIGURE 3 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST BY
CLASSIFICATION, 2011-2018 ($ MILLIONS) 50
GLOBAL MARKET FORECAST BY TYPE OF SALES, 2013-2018 50
TABLE 21 GLOBAL SMOKING CESSATION MEDICINES BY TYPE OF SALES 50
TABLE 22 SMOKING CESSATION MEDICINES FORECAST BY TYPE OF SALES,
THROUGH 2018 ($ MILLIONS) 51
FIGURE 4 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST BY TYPE OF
SALES, 2011-2018 ($ MILLIONS) 51
GLOBAL SMOKING CESSATION MEDICINE MARKET FORECAST BY CATEGORY,
2013-2018 52
TABLE 23 SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY CATEGORY,
THROUGH 2018 ($ MILLIONS) 53
FIGURE 5 SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY CATEGORY,
2011-2018 ($ MILLIONS) 53
GLOBAL NICOTINE REPLACEMENT THERAPY MARKET FORECAST BY CATEGORY,
2013-2018 55
TABLE 24 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET FORECAST BY
CATEGORY, THROUGH 2018 ($ MILLIONS) 56
FIGURE 6 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET FORECAST BY
CATEGORY, 2011-2018 ($ MILLIONS) 56

CHAPTER 6 LEADING MARKETS FOR SMOKING CESSATION MEDICINES 59

GLOBAL MARKET FORECAST BY REGION FOR SMOKING CESSATION MEDICINES,
2013-2018 59
EMERGING MARKETS ARE NEW TARGET MARKETS FOR SMOKING
CESSATION, THROUGH 2018 59
Quit Rates are High in Developed Countries 59
Decrease in Smoking Rates Have Reached Saturation Point in
Developed Markets 60
Smoking Rates are Increasing in Developing Markets 60
STRATEGIC INITIATIVES TO INCREASE SMOKING CESSATION IN
DEVELOPING COUNTRIES 60
Developing and Poor Countries Sign WHO FCTC Treaty 61
WHO FCTC Progress Report 2012 61
TABLE 25 ARTICLES REPORTING HIGHEST IMPLEMENTATION RATES: 2012 WHO
FCTC PROGRESS REPORT (%) 62
TABLE 26 ARTICLES REPORTING MODERATE IMPLEMENTATION RATES: 2012 WHO
FCTC PROGRESS REPORT (%) 62
TABLE 27 ARTICLES REPORTING LOWEST IMPLEMENTATION RATES: 2012 WHO
FCTC PROGRESS REPORT (%) 63
FIGURE 7 GLOBAL IMPLEMENTATION OF ARTICLES: 2012 FCTC REPORT (%) 63
TABLE 28 GLOBAL IMPLEMENTATION OF FCTC ARTICLES: 2012 REPORT 64
Implementation of Article 14 in 2012 66
TABLE 29 GLOBAL IMPLEMENTATION OF ARTICLE 14 OF FCTC, 2012 67
TABLE 30 SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 69
FIGURE 8 SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY REGION,
2011-2018 ($ MILLIONS) 69
THE U.S.: SMOKING CESSATION MARKET 70
CIGARETTE SMOKING DECLINES IN THE U.S. 71
THE U.S. SMOKING CESSATION MEDICINE MARKET 71
TABLE 31 SMOKING CESSATION BRANDS IN THE U.S. MARKET, 2012 72
NEW ENTRANTS EYE THE U.S. MARKET 72
THE U.S.: SMOKING CESSATION MARKET REVENUE, 2012 73
THE U.S.: MARKET FORECAST FOR SMOKING CESSATION MEDICINES,
2013-2018 73
TABLE 32 SMOKING CESSATION MEDICINE MARKET IN THE U.S., THROUGH 2018 ($
MILLIONS) 73
FIGURE 9 SMOKING CESSATION MEDICINE MARKET IN THE U.S., 2011-2018 ($
MILLIONS) 73
CANADA: SMOKING CESSATION MARKET 74
CANADA SMOKING CESSATION MEDICINE MARKET 75
TABLE 33 SMOKING CESSATION BRANDS IN CANADA MARKET: 2012 76
NEW ENTRANTS IN CANADIAN MARKET 76
CANADA: SMOKING CESSATION MARKET REVENUE 2012 76
CANADA: MARKET FORECAST FOR SMOKING CESSATION MEDICINES,
2013-2018 77
TABLE 34 SMOKING CESSATION MEDICINE MARKET IN CANADA, THROUGH 2018 ($
MILLIONS) 77
EUROPE: SMOKING CESSATION MEDICINE MARKET 77
TABLE 35 SMOKING CESSATION BRANDS IN EUROPEAN MARKET: 2012 78
EUROPE: SMOKING CESSATION MARKET REVENUE, 2012 78
EUROPE: MARKET FORECAST FOR SMOKING CESSATION MEDICINES, 2013-2018 79
TABLE 36 SMOKING CESSATION MEDICINE MARKET IN EUROPE, THROUGH 2018 ($
MILLIONS) 79
FIGURE 10 SMOKING CESSATION MEDICINE MARKET IN EUROPE, 2011-2018 ($
MILLIONS) 79
THE U.K.: SMOKING CESSATION MEDICINE MARKET 80
TOBACCO INDUSTRY IN THE U.K. 80
SMOKING BANS AND REGULATING NICOTINE PRODUCTS 80
THE U.K.: SMOKING CESSATION MARKET REVENUE, 2012 81
TABLE 37 SMOKING CESSATION BRANDS IN THE U.K. MARKET: 2012 81
THE U.K.: MARKET FORECAST FOR SMOKING CESSATION MEDICINES,
2013-2018 82
TABLE 38 SMOKING CESSATION MEDICINE MARKET IN THE U.K., THROUGH 2018 ($
MILLIONS) 82
FIGURE 11 SMOKING CESSATION MEDICINE MARKET IN THE U.K., 2011-2018 ($
MILLIONS) 82
FRANCE: SMOKING CESSATION MEDICINE MARKET 83
FRANCE: MARKET FORECAST FOR SMOKING CESSATION MEDICINES, 2013-2018 84
TABLE 39 SMOKING CESSATION MEDICINE MARKET IN FRANCE, THROUGH 2018 ($
MILLIONS) 84
FIGURE 12 SMOKING CESSATION MEDICINE MARKET IN FRANCE, 2011-2018 ($
MILLIONS) 84
OTHER PROMISING EUROPEAN MARKETS 85
GERMANY HAS LOW POTENTIAL FOR SMOKING CESSATION MEDICATION 85
ASIA PACIFIC: SMOKING CESSATION MEDICINE MARKET 85
TABLE 40 SMOKING CESSATION MEDICINE MARKET IN ASIA PACIFIC, THROUGH
2018 ($ MILLIONS) 86
AUSTRALIA: SMOKING CESSATION MEDICINE MARKET 87
TABLE 41 SMOKING CESSATION BRANDS IN AUSTRALIA MARKET: 2012 88
AUSTRALIA: MARKET FORECAST FOR SMOKING CESSATION MEDICINES,
2013-2018 88
TABLE 42 SMOKING CESSATION MEDICINE MARKET IN AUSTRALIA, THROUGH 2018
($ MILLIONS) 88
NEW ZEALAND: SMOKING CESSATION MEDICINE MARKET 89
TABLE 43 SMOKING CESSATION BRANDS IN NEW ZEALAND MARKET: 2012 90
JAPAN: SMOKING CESSATION MEDICINE MARKET 91
JAPAN: MARKET FORECAST FOR SMOKING CESSATION MEDICINES, 2013-2018 92
EMERGING MARKETS FOR SMOKING CESSATION MEDICINES 92
TABLE 44 SMOKING CESSATION MEDICINE MARKET IN EMERGING MARKETS,
THROUGH 2018 ($ MILLIONS) 93
EMERGING MARKETS: MARKET FORECAST FOR SMOKING CESSATION
MEDICINES, 2013-2018 93
CHINA: SMOKING CESSATION MEDICINE MARKET 93
SMOKING PREVALENCE AND TOBACCO CONTROL INITIATIVES 93
SMOKING CESSATION MEDICINE MARKET IN CHINA 95
CHINA: MARKET FORECAST FOR SMOKING CESSATION MEDICINES, 2013-2018 95
CHINA: MARKET POTENTIAL COULD BE TAPPED THROUGH COPD
TREATMENT 95
INDIA: SMOKING CESSATION MEDICINE MARKET 96
TOBACCO CONTROL INITIATIVES IN INDIA 96
SMOKING CESSATION MEDICINE MARKET IN INDIA 97
TABLE 45 SMOKING CESSATION BRANDS IN INDIAN MARKET: 2012 98
GENERIC BUPROPION HCL LEADS INDIAN MARKET FOR SMOKING
CESSATION 98
INDIA: MARKET FORECAST FOR SMOKING CESSATION MEDICINES, 2013-2018 99
TABLE 46 SMOKING CESSATION MEDICINE MARKET IN INDIA, THROUGH 2018 ($
MILLIONS) 99
BRAZIL: SMOKING CESSATION MEDICINE MARKET 99
SMOKING CESSATION MEDICINE MARKET IN BRAZIL 100
TABLE 47 SMOKING CESSATION BRANDS IN BRAZILIAN MARKET, 2012 100
BRAZIL: MARKET FORECAST FOR SMOKING CESSATION MEDICINES, 2013-2018 101
TABLE 48 SMOKING CESSATION MEDICINE MARKET IN BRAZIL, THROUGH 2018 ($
MILLIONS) 101

CHAPTER 7 SMOKING CESSATION INDUSTRY AND MARKET ANALYSES 103

GLOBAL MARKET FOR SMOKING CESSATION MEDICINES 104
PESTLE ANALYSIS 104
Political and Legal Interventions Influence Markets 104
TABLE 49 INITIATIVES IMPLEMENTED BY PARTIES TO FCTC TREATY (%) 106
Socioeconomic Factors 106
TABLE 50 PROJECTED GLOBAL CAUSE OF DEATH (%) 108
TABLE 51 PUBLIC HEALTH BURDEN DUE TO SMOKING-RELATED DISEASES ($
BILLIONS) 108
Technology Developments 108
FIGURE 13 GLOBAL STUDIES ON TOBACCO DEPENDENCE AND SMOKING
CESSATION, BY REGION (NO. OF ONGOING STUDIES) 109
TABLE 52 SWOT ANALYSIS OF SMOKING CESSATION MEDICINES 110
COMPETITIVE ANALYSIS AND BENCHMARKING 111
TOBACCO TRANSFORMATION STRATEGY 111
DIFFERENTIATION BETWEEN SMOKING CESSATION MEDICINES AND
ALTERNATIVES TO CIGARETTES 112
TABLE 53 COMPARING SMOKING CESSATION MEDICINES AND OTHER NICOTINE
DELIVERY SYSTEMS 112
COLLABORATIONS AND COMBINATIONS 112
INDUSTRY OPINION ON FUTURE OF THE SMOKING CESSATION MEDICINE
INDUSTRY 113
UNTAPPED POTENTIAL OF SMOKING CESSATION MARKET COULD BE $60
BILLION 114

CHAPTER 8 COMPANY PROFILES 116

22ND CENTURY GROUP INC. 116
ACTAVIS, INC. 116
ALKALON A/S 117
BIOTA PHARMACEUTICALS, INC. 117
BIOTIE THERAPIES CORP. 117
BOEHRINGER INGELHEIM GMBH 118
CELTIC PHARMA MANAGEMENT L.P. 118
CIPLA LTD. 118
CYTOS BIOTECHNOLOGY AG 119
EVOTEC AG 119
FERTIN PHARMA A/S 119
GENTECH HEALTHCARE 120
GLAXOSMITHKLINE PLC 120
JOHNSON and JOHNSON 121
MCNEIL CONSUMER HEALTHCARE 121
NICONOVUM AB 121
NOVARTIS INTERNATIONAL AG 122
PERRIGO CO. 122
PFIZER INC. 122
PIERRE FABRE PHARMACEUTICALS INC. 123
LABORATOIRES PIERRE FABRE 123
PSYCOREMEDIES 123
REVOLYMER (U.K.) LTD. 124
SANOFI 124
SOMAXON PHARMACEUTICALS INC. 124
SOPHARMA AD 125
SUN PHARMACEUTICAL INDUSTRIES LTD. 125
TAISHO PHARMACEUTICAL HOLDINGS 125
TAKEDA PHARMACEUTICALS LTD. 126
TARGACEPT, INC. 126
WALGREENS 126
ZENARA PHARMACEUTICALS 127



LIST OF TABLES

SUMMARY TABLE SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY
REGION, THROUGH 2018 ($ MILLIONS) 8
TABLE 1 BENEFITS OF SMOKING CESSATION 19
TABLE 2 GENERAL CRITERIA FOR DRUG DEPENDENCE 23
TABLE 3 CLASSIFICATION OF SMOKING CESSATION MEDICINES BASED ON MODE OF
ACTION 29
TABLE 4 CLASSIFICATION OF NICOTINE REPLACEMENT THERAPY BASED ON DRUG
DELIVERY SYSTEM 29
TABLE 5 NICOTINE GUM DOSAGES AND SCHEDULES 30
TABLE 6 KEY BRANDS AND MARKETERS OF NICOTINE GUMS 32
TABLE 7 NICOTINE LOZENGE DOSAGE AND SCHEDULE 32
TABLE 8 KEY BRANDS AND MARKETERS OF NICOTINE LOZENGES 33
TABLE 9 KEY BRANDS AND MARKETERS OF NICOTINE TABLETS 34
TABLE 10 KEY BRANDS AND MARKETERS OF NICOTINE INHALERS 34
TABLE 11 KEY BRANDS AND MARKETERS OF NICOTINE MOUTH SPRAYS 35
TABLE 12 NICOTINE PATCH DOSAGE AND SCHEDULE 36
TABLE 13 KEY BRANDS AND MARKETERS OF NICOTINE PATCHES 37
TABLE 14 KEY BRANDS AND MARKETERS OF NICOTINE NASAL SPRAYS 37
TABLE 15 CHANTIX/CHAMPIX SALES REVENUE, 2007-2012 ($ MILLIONS) 39
TABLE 16 NICOTINE VACCINES IN DEVELOPMENT PHASE AS OF JANUARY 2013 41
TABLE 17 DEVELOPMENTS IN THE PIPELINE (NON-NICOTINE) 43
TABLE 18 CLINICAL TRIALS OF D-CYCLOSERINE 44
TABLE 19 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST, THROUGH
2018 ($ MILLIONS) 48
TABLE 20 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST BY
CLASSIFICATION, THROUGH 2018 ($ MILLIONS) 49
TABLE 21 GLOBAL SMOKING CESSATION MEDICINES BY TYPE OF SALES 50
TABLE 22 SMOKING CESSATION MEDICINES FORECAST BY TYPE OF SALES,
THROUGH 2018 ($ MILLIONS) 51
TABLE 23 SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY CATEGORY,
THROUGH 2018 ($ MILLIONS) 53
TABLE 24 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET FORECAST BY
CATEGORY, THROUGH 2018 ($ MILLIONS) 56
TABLE 25 ARTICLES REPORTING HIGHEST IMPLEMENTATION RATES: 2012 WHO
FCTC PROGRESS REPORT (%) 62
TABLE 26 ARTICLES REPORTING MODERATE IMPLEMENTATION RATES: 2012 WHO
FCTC PROGRESS REPORT (%) 62
TABLE 27 ARTICLES REPORTING LOWEST IMPLEMENTATION RATES: 2012 WHO FCTC
PROGRESS REPORT (%) 63
TABLE 28 GLOBAL IMPLEMENTATION OF FCTC ARTICLES: 2012 REPORT 64
TABLE 29 GLOBAL IMPLEMENTATION OF ARTICLE 14 OF FCTC, 2012 67
TABLE 30 SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 69
TABLE 31 SMOKING CESSATION BRANDS IN THE U.S. MARKET, 2012 72
TABLE 32 SMOKING CESSATION MEDICINE MARKET IN THE U.S., THROUGH 2018 ($
MILLIONS) 73
TABLE 33 SMOKING CESSATION BRANDS IN CANADA MARKET: 2012 76
TABLE 34 SMOKING CESSATION MEDICINE MARKET IN CANADA, THROUGH 2018 ($
MILLIONS) 77
TABLE 35 SMOKING CESSATION BRANDS IN EUROPEAN MARKET: 2012 78
TABLE 36 SMOKING CESSATION MEDICINE MARKET IN EUROPE, THROUGH 2018 ($
MILLIONS) 79
TABLE 37 SMOKING CESSATION BRANDS IN THE U.K. MARKET: 2012 81
TABLE 38 SMOKING CESSATION MEDICINE MARKET IN THE U.K., THROUGH 2018 ($
MILLIONS) 82
TABLE 39 SMOKING CESSATION MEDICINE MARKET IN FRANCE, THROUGH 2018 ($
MILLIONS) 84
TABLE 40 SMOKING CESSATION MEDICINE MARKET IN ASIA PACIFIC, THROUGH 2018
($ MILLIONS) 86
TABLE 41 SMOKING CESSATION BRANDS IN AUSTRALIA MARKET: 2012 88
TABLE 42 SMOKING CESSATION MEDICINE MARKET IN AUSTRALIA, THROUGH 2018
($ MILLIONS) 88
TABLE 43 SMOKING CESSATION BRANDS IN NEW ZEALAND MARKET: 2012 90
TABLE 44 SMOKING CESSATION MEDICINE MARKET IN EMERGING MARKETS,
THROUGH 2018 ($ MILLIONS) 93
TABLE 45 SMOKING CESSATION BRANDS IN INDIAN MARKET: 2012 98
TABLE 46 SMOKING CESSATION MEDICINE MARKET IN INDIA, THROUGH 2018 ($
MILLIONS) 99
TABLE 47 SMOKING CESSATION BRANDS IN BRAZILIAN MARKET, 2012 100
TABLE 48 SMOKING CESSATION MEDICINE MARKET IN BRAZIL, THROUGH 2018 ($
MILLIONS) 101
TABLE 49 INITIATIVES IMPLEMENTED BY PARTIES TO FCTC TREATY (%) 106
TABLE 50 PROJECTED GLOBAL CAUSE OF DEATH (%) 108
TABLE 51 PUBLIC HEALTH BURDEN DUE TO SMOKING-RELATED DISEASES ($
BILLIONS) 108
TABLE 52 SWOT ANALYSIS OF SMOKING CESSATION MEDICINES 110
TABLE 53 COMPARING SMOKING CESSATION MEDICINES AND OTHER NICOTINE
DELIVERY SYSTEMS 112



LIST OF FIGURES

SUMMARY FIGURE SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY
REGION, 2011-2018 ($ MILLIONS) 8
FIGURE 1 NICOTINE MOLECULE: 3-[(2S)-1-METHYLPYRROLIDINE-2-YL]PYRIDINE 21
FIGURE 2 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST, 2011-2018
($ MILLIONS) 48
FIGURE 3 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST BY
CLASSIFICATION, 2011-2018 ($ MILLIONS) 50
FIGURE 4 SMOKING CESSATION MEDICINE GLOBAL MARKET FORECAST BY TYPE OF
SALES, 2011-2018 ($ MILLIONS) 51
FIGURE 5 SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY CATEGORY,
2011-2018 ($ MILLIONS) 53
FIGURE 6 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET FORECAST BY
CATEGORY, 2011-2018 ($ MILLIONS) 56
FIGURE 7 GLOBAL IMPLEMENTATION OF ARTICLES: 2012 FCTC REPORT (%) 63
FIGURE 8 SIZE OF GLOBAL SMOKING CESSATION MEDICINE MARKET BY REGION,
2011-2018 ($ MILLIONS) 69
FIGURE 9 SMOKING CESSATION MEDICINE MARKET IN THE U.S., 2011-2018 ($
MILLIONS) 73
FIGURE 10 SMOKING CESSATION MEDICINE MARKET IN EUROPE, 2011-2018 ($
MILLIONS) 79
FIGURE 11 SMOKING CESSATION MEDICINE MARKET IN THE U.K., 2011-2018 ($
MILLIONS) 82
FIGURE 12 SMOKING CESSATION MEDICINE MARKET IN FRANCE, 2011-2018 ($
MILLIONS) 84
FIGURE 13 GLOBAL STUDIES ON TOBACCO DEPENDENCE AND SMOKING CESSATION,
BY REGION (NO. OF ONGOING STUDIES) 109

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Sleep Aids: Technologies and Global Markets

Sleep Aids: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Analyze the current market dynamics and evaluate the effect of strategic factors such as technology-driven change and industry consolidation of sleep aids and technologies. - Review ...

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

This BCC Research report presents a comprehensive look at disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options. Forecast included from 2016 through 2021. ...

Flavored and Functional Water Market - Brazil Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Flavored and Functional Water Market - Brazil Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Brazil Flavored and Functional Water Market: Overview and Trends Transparency Market Research (TMR) offers 8-year forecast for the Brazil flavored and functional water market between 2016 and 2024. In ...


Download Unlimited Documents from Trusted Public Sources

Soybean Markets in Spain

  • December 2016
  • Soybean  

    Food  

    Milk  

  • Spain  

    Europe  

View report >

OTC Industry in Malaysia

  • November 2016
    10 pages
  • OTC  

  • Malaysia  

View report >

Pain Relief Industry in the US

  • November 2016
    31 pages
  • Pain Relief  

    Stroke  

  • United States  

View report >

Otc Markets In India

27 days ago

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.